Skip to content

Effect of Auriculotherapy in treatment of Covid 19

The effect of Auriculotherapy on Clinical finding of Covid 19

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180608040007N2
Enrollment
70
Registered
2020-06-13
Start date
2020-04-28
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid19. COVID 19

Interventions

Intervention 1: Intervention group:First, 15 minutes is explained about orchicotherapy, and after disinfecting the ear with 70% alcohol and drying the spots: Thymus gland, Adrenal, lung 1 & 2, Throat,

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients hospitalized for infectious parts suspected of having covid 19 Age from 10 to 70 years Having a healthy double ear (for uricotherapy) Participants self-reported for: no depression, no psychotropic medications, no pacemakers, no platinum or no metal objects in the body

Exclusion criteria

Exclusion criteria: Swelling, infection and sores in both ears in the intervention group Use of psychotropic drugs, antidepressants Occurrence of stressful events such as the death of loved ones, unfortunate events The desire to end treatment Worsening of the patient's condition and the need for an ICU

Design outcomes

Primary

MeasureTime frame
Improving the clinical course. Timepoint: Daily control of clinical symptoms up to 7 days after uricycliotherapy. Method of measurement: Arterial oxygen with pulse oximeter, anxiety with questionnaire, sleep quality with questionnaire,.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mohammadi

Yazd University of Medical Sciences

ba_zendegy@yahoo.com+98 35 3822 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026